Title: In situ Analysis of Drug-target Interaction

Prof. Chen specializes in novel drug-target interaction analysis technologies, applying them to drug screening, visual activity evaluation, and clinical point-of-care testing. He has led 15 national and provincial projects, including the National Key R&D Program and NSFC Outstanding Youth projects. Prof. Chen authored over 70 first/corresponding author papers in prestigious journals (e.g., Adv. Mater., Sci. Adv.), with 41 Q1 papers, 2 ESI hot/highly cited, and over 2000 total citations. He holds 8 authorized national invention patents and was instrumental in the development of a Class 2 new drug that completed Phase III clinical trials. His professional service includes Vice Executive Secretary for the Pharmaceutical Analysis Technology Branch of the Chinese Medical Biotechnology Society and a youth editorial board member for several academic journals. He is a lead recipient of the China Pharmaceutical Association and Shanghai Pharmaceutical Science and Technology Second Prizes.